Stork E
Department of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, Ohio.
Clin Perinatol. 1988 Dec;15(4):815-29.
Extracorporeal membrane oxygenation (ECMO) has gained notoriety recently as a treatment of last resort for neonates at term or near term who suffer from pulmonary failure. Because of serious inherent risks, the procedure is at present reserved for infants with reversible pulmonary disease who have failed conventional or high-frequency ventilation and who meet the prognostic criterion of 80 percent mortality.
体外膜肺氧合（ECMO）最近作为足月或接近足月患有肺衰竭的新生儿的最后治疗手段而声名狼藉。由于存在严重的固有风险，目前该手术仅适用于患有可逆性肺部疾病、常规或高频通气治疗失败且符合80%死亡率预后标准的婴儿。
